Login / Signup

Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial.

Niraj M DesaiSherry G LeungJennifer D MotterDorry L SegevDaniel S WarrenChristine M Durand
Published in: Annals of internal medicine (2023)
Keyphrases
  • kidney transplantation
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label